The presence of some fungal species in tumors predicts – and may even help drive – worse cancer outcomes, according to a study from Weill Cornell Medicine and Duke University researchers.
The upgrades reflect Martha Van Rensselaer’s original philosophy for the College of Human Ecology, and the innovative, multidisciplinary institution it has evolved into over time.
White blood cells called neutrophils have an unappreciated role in eradicating solid tumors, according to a surprise discovery from a team led by Weill Cornell Medicine scientists.
Vaccination with a SARS-CoV-2 mRNA vaccine revealed HIV hiding in immune cells in blood from people with HIV, according to lab research led by Weill Cornell Medicine investigators.
An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.
Cornell is creating unique opportunities for innovation in the rapidly evolving field of structural biology thanks to cutting-edge facilities and support for intercampus collaborations between Cornell's Ithaca campus and Weill Cornell Medicine.
Cole, M.D. ’94, is the assistant vice provost for information services and chief information officer at Weill Cornell Medicine. He will begin his new role Jan. 1, 2023.
Small proteins that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study.
From new approaches for tendon injury treatment to biomass-based construction materials, Cornell Engineering’s inaugural Sprout Awards are funding unique research projects with the potential to grow partnerships across Cornell.